Abstract-Previous studies in transgenic mice and with isolated ryanodine receptors (RyR) have indicated that Ca 2ϩ -calmodulin-dependent protein kinase II (CaMKII) can phosphorylate RyR and activate local diastolic sarcoplasmic reticulum (SR) Ca 2ϩ release events (Ca 2ϩ sparks) and RyR channel opening. Here we use relatively controlled physiological conditions in saponin-permeabilized wild type (WT) and phospholamban knockout (PLB-KO) mouse ventricular myocytes to test whether exogenous preactivated CaMKII or endogenous CaMKII can enhance resting Ca 2ϩ sparks. PLB-KO mice were used to preclude ancillary effects of CaMKII mediated by phospholamban phosphorylation. In both WT and PLB-KO myocytes, Ca 2ϩ spark frequency was increased by both preactivated exogenous CaMKII and endogenous CaMKII. This effect was abolished by CaMKII inhibitor peptides. In contrast, protein kinase A catalytic subunit also enhanced Ca 2ϩ spark frequency in WT, but had no effect in PLB-KO. 
C ardiac ryanodine receptors (RyR2) are central in excitation contraction coupling (ECC) both as the sarcoplasmic reticulum (SR) Ca 2ϩ release channel and as a scaffolding protein that localizes numerous regulatory proteins to the junctional complex. 1 Ca 2ϩ sparks reflect the synchronous activation of a cluster of Ϸ6 to 20 RyR at a single junction, producing both the diastolic SR Ca 2ϩ leak and the temporally synchronized SR Ca 2ϩ release during ECC. [1] [2] [3] Their activity can be modulated by many factors including divalent cations, adenine nucleotides, calmodulin (CaM), caffeine, oxidation, and phosphorylation. 1, 2 Protein kinase A (PKA)-dependent RyR phosphorylation has been reported to increase RyR open probability at the single channel level. 4 -6 It was further suggested that hyperphosphorylation of RyR at Ser 2809 by PKA in heart failure (HF) caused dissociation of FK-506 binding protein (FKBP12.6) from the RyR, resulting in enhanced diastolic Ca 2ϩ leak, reduced SR Ca 2ϩ content, and contractile dysfunction. 7 However, Li et al 8 found that cAMP-induced RyR phosphorylation had no effect on resting RyR-mediated SR Ca 2ϩ leak (assessed via Ca 2ϩ sparks) in phospholamban (PLB) knockout mouse myocytes (PLB-KO). It remains controversial whether PKA-dependent RyR phosphorylation does occur in HF and whether it causes dissociation of FKBP12.6 from RyR or mediates enhanced SR Ca 2ϩ leak. [8] [9] [10] /calmodulin-dependent protein kinase II (CaMKII) has been reported to phosphorylate or regulate L-type Ca 2ϩ current (I Ca ), PLB, and RyR. [11] [12] [13] [14] [15] [16] At the single-channel recording level, reports suggest that CaMKII can either enhance 5, 16, 17 or depress RyR activity. 18 However, in voltage clamped intact myocytes, Li et al 19 reported that endogenous CaMKII increased SR Ca 2ϩ release for a given SR Ca 2ϩ content and I Ca trigger. In addition, protein phosphatases (PP1 and PP2A) can reduce SR Ca 2ϩ release channel activity for a given SR load and I Ca, 20 but can also enhance Ca 2ϩ spark frequency. 21 Moreover, in transgenic mice overexpressing CaMKII␦ C , fractional SR Ca 2ϩ release was enhanced and resting spontaneous SR Ca 2ϩ spark frequency was dramatically increased, despite lower SR Ca 2ϩ load and lower diastolic [Ca 2ϩ ] i . 22 Moreover, CaMKII is associated with RyR 22 and is upregulated in heart failure, 22 where SR Ca 2ϩ leak may contribute to systolic dysfunction and arrhythmogenesis. 22 The goal here was to test the effects of CaMKII on resting SR Ca 2ϩ release (as Ca 2ϩ sparks) in saponin-permeabilized mouse ventricular myocytes (wild type [WT] and PLB-KO). Activation of endogenous CaMKII or application of preactivated exogenous CaMKII (autophosphorylated) resulted in RyR phosphorylation and enhanced resting Ca 2ϩ spark frequency (CaSpF), independent of SR Ca 2ϩ load. CaM also depressed RyR activity with a half-maximal effect at 100-nM CaM.
Methods

Cardiac Myocyte Isolation
Mouse ventricular myocytes were enzymatically isolated as previously described (see the online data supplement, available at http:// circres.ahajournals.org), 8 and PLB-KO mice were provided by Dr E.G. Kranias (University of Cincinnati, OH). Procedures were performed according to Guiding Principles in the Care and Use of the Animals approved by the Council of the American Physiological Society.
Ca
2؉ Sparks in Permeabilized Myocytes
Myocytes were permeabilized with saponin (50 g/mL) 
Activation of Endogenous CaMKII
To activate endogenous CaMKII in permeabilized ventricular myocytes [Ca 2ϩ ] i was elevated for 1 minute to 500 nM with 1.2 mol/L exogenous CaM. Phosphatase inhibitor OA (2 mol/L) was included to prevent dephosphorylation of CaMKII and its targets, and 15 mol/L PKI was included.
Preactivation of Exogenous CaMKII
We also used preactivated exogenous CaMKII. CaMKII␣ (12 mg/mL; gift from Dr J.H. Brown, University of California, San Diego) was preactivated (autophosphorylated) by incubation with (in mol/L): ATP 100, CaM 2.4, and CaCl 2 200 for 10 minutes at 37°C. In some experiments, CaMKII inhibitor AIP (1 mol/L) was included as a negative control. Preactivated CaMKII was then rapidly diluted into final superfusate with free [Ca 2ϩ ] restored to 50 nM (with 6 g/mL CaMKII, 1.2 mol/L CaM, 10 mol/L OA, and 15 mol/L PKI) and exposed to permeabilized myocytes.
Immunoprecipitation and CaMKII Phosphorylation of RyR2
RyR2 was immunoprecipitated from homogenate or cell lysate with antibody (MA3-916, Affinity BioReagents) in 0.5 mL of 62.5 mmol/L Tris-HCl buffer (pH 7.5), 0.9% NaCl, 0.5 mmol/L NaF, 1% Triton-X, and protease inhibitors for 2 hours at 4°C (see the online supplement for details). CaMKII phosphorylation of immunoprecipitated RyR2 was initiated by adding autophosphorylated CaMKII and ␥P 32 -ATP (final specific activity 300 Ci/mol). Reactions were terminated with stop solution (10% sodium dodecyl sulfate, 300 mmol/L EGTA, and 0.25 mmol/L DTT) and sizefractionated on 5% SDS-PAGE, and RyR2 radioactivity was quantified using Unscan-it software. RyR2 protein was determined by immunoblotting. FKBP12.6 was measured 6 using anti-FKBP12 (supplied by Dr A.R. Marks, Columbia University, New York; see the online supplement).
Data Analysis
Ca 2ϩ sparks were analyzed as previously described (see the online supplement). 8 Ca 2ϩ spark amplitudes were normalized to fluorescence baseline (F 0 ) as F/F 0 , duration was full-duration half-maximum (FDHM), and width was full-width half-maximum (FWHM). Results are expressed as meanϮSEM. Significance (PϽ0.05) was determined using Student t test.
Results
Exogenous CaMKII on Ca 2؉ Sparks and SR Ca 2؉ Content in WT mice Figure 1A shows representative line scan images from a WT myocyte before, during application of preactivated CaMKII␣ with CaM, and following washout of CaM/CaMKII␣ (with dephosphorylation inhibited by OA). Figure 1B shows mean data, where CaSpF did not increase during CaM/CaMKII exposure for 5 minutes (205Ϯ20 versus 199Ϯ39 sparks pl Ϫ1 s Ϫ1 ), but 5 minutes after washout of CaM/CaMKII CaSpF greatly increased (by 108%, nϭ10) versus control.
The dramatic increase in CaSpF during CaM/CaMKII washout is consistent with CaMKII-dependent activation of RyR. However, the failure to see increased CaSpF during CaM/CaMKII exposure could be attributable to an acute inhibitory effect of CaM (examined below).
CaMKII can phosphorylate PLB to cause increased SR Ca 2ϩ uptake and content, and CaSpF depends strongly on SR Ca 2ϩ content. 1, 8 Figure 1C shows that after exposure to CaMKII there was a small (14%), but significant increase in SR Ca 2ϩ content (assessed by caffeine-induced Ca 2ϩ transients). Given the steep leak versus SR Ca 2ϩ content relationship, 1, 8 we cannot rule out the possibility that part of the 108% increase in CaSpF after CaMKII exposure was secondary to the 14% increase in SR Ca 2ϩ content.
Exogenous CaMKII on Ca 2؉ Sparks and SR Ca 2؉ 
Content in PLB-KO Mice
To eliminate the potential complicating effect of CaMKII on PLB we repeated the same protocol in PLB-KO mice ( Figure  2 ). In PLB-KO myocytes, CaM/CaMKII␣ addition raised the mean CaSpF by 28%, but not significantly (Pϭ0.06). After washout, CaSpF increased significantly by 60% (PϽ0.0001, nϭ9; Figure 2B ). In PLB-KO myocytes, SR Ca 2ϩ content was not increased by exposure to activated CaMKII ( Figure 2C) . Thus, the increased CaSpF cannot be secondary to increased SR Ca 2ϩ content, but could be caused by CaMKII-dependent RyR modulation. As a control, these experiments were also done with CaMKII inhibitory peptide AIP in the CaMKII preactivation cocktail. Figure 2D shows that AIP prevented the increase in CaSpF. Thus CaMKII activity is required for the observed increase in CaSpF.
There were small, but significant changes in Ca 2ϩ spark characteristics (Table) CaM-dependent RyR inhibition as observed in bilayer and SR vesicle studies. 23, 24 To test whether CaM had direct effects on RyR (versus via CaMKII), we applied different CaM concentrations to myocytes under conditions where CaMKII should not be activated: (1) Figure 3A) and (2) Figure 3B ). The right panels of Figure 3 show that CaM decreased CaSpF in a dose-dependent manner with halfinhibition at Ϸ100 nM CaM (K 0.5 ) in both WT and PLB-KO myocytes. Furthermore, the inhibitory effect was partially reversed by CaM washout ( Figure 3A and 3B). CaM did not alter Ca 2ϩ spark properties (not shown). In other PLB-KO myocytes where AIP was not included, very high CaM (Ն2 mol/L) increased CaSpF in a minority of cells (2 out 6), an effect never observed at low CaM concentration or when AIP was included ( Figure 3B ). This may be because of some degree of CaMKII activation at very high CaM (despite low [Ca 2ϩ ] i ). This unexpected increase of CaSpF could be abolished by AIP, supporting our conclusion that RyRs are activated by CaMKII but inhibited by CaM.
In Vitro Time-Dependent RyR Phosphorylation by CaMKII
To test whether our preactivation approach can phosphorylate RyR, we measured 32 P incorporation in immunoprecipitated RyRs ( Figure 4A, nϭ4 ). In the absence of OA, RyR phosphorylation by CaMKII␣ reached a peak in 5 to 8 minutes (normalized to RyR loading for each sample), but declined at 10 minutes. However, with OA, 32 P incorporation reached a higher maintained peak at 8 minutes. This raises 2 points. First, our preactivated CaMKII␣ readily phosphorylates RyR, and second, phosphatases that coimmunoprecipitate with RyR2 may limit phosphate incorporation. The decline of 32 P at 8 to 10 minutes without OA might be partly caused by the exhaustion of 32 P-ATP available (and dephosphorylation), because [ATP] was lower here than in the Ca 2ϩ spark measurements (100 mol/L versus 5 mmol/L) to optimize 32 P specific activity.
Exogenous PKA and CaSpF
The approach used here previously showed that cAMPdependent RyR phosphorylation could increase CaSpF in WT, but not in PLB-KO mice (or where only nonphosphorylatable PLB was expressed). 8 Here, we further test whether exogenous PKA catalytic subunit alters CaSpF, as we see for preactivated CaMKII. Figure 4B shows that exogenous PKA increased CaSpF in WT, but not in PLB-KO. These results with active PKA agree with the earlier results with cAMP (which depended on endogenous PKA). 8 However, the PKA results contrast dramatically with the present results with activated CaMKII.
Because the PKA effect on RyR may depend on dissociation of FKBP12.6, we also measured FKBP12/12.6 expression and RyR association. There is no change in total FKBP12 expression in PLB-KO versus WT hearts (Figure 4C). Nor was there any difference in FKBP12.6, which coimmunoprecipitates with RyR2 in control conditions or after treatment with PKA or PKI ( Figure 4D ). We also did not find any appreciable loss of RyR-associated FKBP12.6 on myocyte permeabilization as used here (not shown). Thus, we did not detect FKBP12.6 dissociation under conditions where in WT myocytes there was enhanced CaSpF (presumably because of PLB phosphorylation, enhanced SR Ca-ATPase activity, and SR Ca content). 8 
Time-Dependent CaMKII Phosphorylation of RyR
Endogenous CaMKII on Ca 2؉ Sparks in Permeabilized Myocytes
Since endogenous CaMKII␦ is known to associate with the RyR, 17,25-27 we sought to test whether endogenous CaMKII can activate RyR in myocytes as seen above for exogenous CaMKII. Figure 5A shows line scans during a 5-minute control period, as [Ca 2ϩ ] i was elevated to 500 nM (with 1.2 mol/L CaM, 15 mol/L PKI, and 2 mol/L OA added to activate endogenous CaMKII) and on washout (where CaM was removed and [Ca 2ϩ ] i restored to the initial level). Figure 5B and 5C shows that endogenous CaMKII activation increased CaSpF in both WT and PLB-KO mice (mean for 3 to 12 minutes in sparks pl Ϫ1 s Ϫ1 increased from 139Ϯ31 to 350Ϯ37 in WT, Pϭ0.009, and from 267Ϯ29 to 529Ϯ75 in PLB-KO, Pϭ0.004). Maximum CaSpF occurred within 4 minutes of CaMKII activation and was maintained for the entire 10 minutes studied (OA was present). The same protocol was performed with the specific CaMKII inhibitor peptide (AIP 1 mol/L) included during and after [Ca 2ϩ ] i and CaM elevation. AIP prevented the increase in CaSpF in both WT and PLB-KO ( Figure 5B and 5C). SR Ca 2ϩ content was significantly increased in WT myocytes, but did not change significantly in PLB-KO. This demonstrates that the increased CaSpF was not caused by increased SR load in the PLB-KO. These results are consistent with exogenous CaMKII effects on both PLB and RyR.
In WT myocytes PLB-dependent stimulation of SR CaATPase must be slightly stronger than the enhanced SR Ca 2ϩ leak, resulting in higher SR Ca 2ϩ content. However, in PLB-KO, the enhanced SR Ca 2ϩ leak should lower SR Ca 2ϩ content, but did not. This may be because the SR Ca 2ϩ -ATPase is so active in PLB-KO myocytes that the leak does not greatly depress load (see Figure II in the online supplement). Ca 2ϩ spark amplitude increased in WT myocytes on endogenous CaMKII activation (Table) , possibly because of enhanced SR content and spark duration (FDHM). In PLB-KO, spark amplitude also increased, possibly because of prolonged release duration. Figure 6A shows histograms of Ca 2ϩ spark durations (Ϯ activation of endogenous CaMKII) in PLB-KO myocytes. For control, 90% of Ca 2ϩ sparks were 10 to 40 ms in FDHM, whereas after CaMKII this value was only 77%. There were essentially no Ca 2ϩ sparks with FDHM Ͼ70 ms in control (0.3% of events), but CaMKII increased this to 4.7% of the already more frequent events. Integrating the individual Ca 2ϩ spark events (from longest to shortest duration, Figure 6B) shows that half the Ca 2ϩ sparks are longer than 32 ms in CaMKII versus 26 ms in control. Figure  6C shows that CaMKII activation resulted in occasional macrosparks (that exceed the spatial spread of normal Ca 2ϩ 
Phosphorylation of RyR and PLB in WT Mouse Ventricular Myocytes
Finally, we assessed CaMKII-dependent RyR phosphorylation after treating ventricular myocytes as in the Ca 2ϩ spark measurements. Here we used RyR back-phosphorylation after myocyte incubation by subsequent treatment with CaMKII␣ (and ␥ CaMKII also phosphorylates PLB at Thr-17, and this is a control for CaMKII target phosphorylation. Figure 7A and 7C shows that basal PLB phosphorylation was too low to detect. After treatment with Ca/CaM (even after restoration of [Ca 2ϩ ] i to 50 nM with OA), PLB phosphorylation quickly reached its maximum, with no apparent increase with exogenous CaMKII␣. Thus, both RyR and PLB were highly phosphorylated by treatment of high Ca/CaM, under conditions where CaSpF were evaluated in Figures 5 and 6 .
Discussion
We demonstrated in a controlled mouse PLB-KO myocyte setting that: (1) CaMKII-dependent RyR phosphorylation significantly increases CaSpF and duration, independent of SR Ca 2ϩ content (using both exogenous and endogenous CaMKII), (2) mice in isolating RyR effects mechanistically. It also suggests that these combined actions in normal (or failing) myocytes could be more arrhythmogenic than either alone.
Does RyR Become Phosphorylated by CaMKII Under Physiological Conditions?
Wehrens et al 17 showed that RyR phosphorylation at Ser2815 by CaMKII increases at higher heart rate, and the same was found in isolated myocytes. 33 Increasing heart rate also accelerates SR Ca 2ϩ uptake and normally increases SR Ca 2ϩ content. Thus, under physiological conditions, the sort of CaMKII-dependent RyR regulation described here is likely to be dynamically functional.
PKA-Versus CaMKII-Dependent Changes in Ca 2؉ Sparks
The role of PKA-dependent RyR phosphorylation and enhancement of diastolic leak is controversial, and the field cannot be reviewed here. Briefly, 1 group has a cogent body of evidence from single RyR bilayer gating and extensive biochemical data that phosphorylation of cardiac RyR at S2809 by PKA causes FKBP12.6 dissociation from RyR2, which would increase SR Ca 2ϩ leak and decrease SR Ca 2ϩ content. 6, 7 Other labs have been unable to confirm certain aspects of this hypothesis. 8 -10 Our group could not detect any effect on CaSpF on maximal RyR phosphorylation by endogenous PKA driven by exogenous cAMP in PLB-KO myocyte (in experiments like those described here). 8 Here, we further tested the effect of PKA catalytic subunit on RyR activity (in direct parallel to our CaMKII studies). Again, we found that PKA enhanced CaSpF in WT mouse myocytes (consistent with enhanced SR Ca 2ϩ uptake and content), but had no effect at all on CaSpF in PLB-KO mouse myocytes. This contrasts sharply with profound CaSpF enhancement seen here with both exogenous and endogenous CaMKII in PLB-KO myocytes. Thus, CaMKII has a powerful effect on resting Ca 2ϩ release (versus PKA).
Conceivably, PLB-KO mice have less FKBP12.6, which could mask a PKA effect in those myocytes. However, we found that there was neither a change in the extent of FKBP12.6 expression nor association with the RyR in these myocytes; nor was FKBP12.6 lost from the RyR2 on permeabilization and treatment with PKA or PKI. Thus, we remain unable to detect significant stimulation of CaSpF by PKA (unless PLB is present).
Both PKA and CaMKII affect RyR gating during ECC, when the I Ca trigger and SR Ca 2ϩ content are matched. 19, 34 Notably, PKA has no effect on the amount of SR Ca 2ϩ release, fractional release, or ECC gain, but does enhance the initial rate of SR Ca 2ϩ release (and its turn-off). These effects closely resemble single RyR channel behavior 35 where PKA increased peak RyR opening during a rapid rise in local [Ca 2ϩ ], but accelerated RyR closure as well. This again contrasts with CaMKII, where endogenous CaMKII activation enhances fractional SR Ca 2ϩ release (for a given SR Ca content and I Ca trigger) without greatly altering Ca 2ϩ transient kinetics. 23, 24 Recent findings using overexpression of CaMKII␦ C via trans-genesis or via acute adenoviral transfer agree with this. 22, 30 Different roles of PKA and CaMKII in diastolic Ca 2ϩ release and ECC are consistent with a difference of their molecular basis. Wehrens et al 17 reported that phosphorylation of RyR2 occurs at Ser-2815 by CaMKII and Ser-2809 by PKA, and the 2 kinases produced different RyR gating phenotypes. This is also controversial, as PKA may also phosphorylate RyR2 at Ser2030 and CaMKII may phosphorylate Ser2809 and other unidentified RyR2 sites. 10, 15, 16 Ca 2؉ Leak in Heart Failure: Pathological Implications
CaMKII is upregulated in HF in humans 36 and animals. 27, 37 In an arrhythmogenic rabbit HF model, more CaMKII (and less phosphatase 1 and 2A) is associated with RyR2, CaMKII is more activated (autophosphorylated), and RyR2 is more highly phosphorylated. 27 In addition, there is increased diastolic SR Ca 2ϩ leak that can be inhibited by CaMKII blockers, 27, 38 as was seen on CaMKII overexpression. 22, 30 There was also a decrease in RyR2-bound CaM in this HF model, 27 
METHODS (expanded)
Cardiac Myocyte Isolation Single mouse ventricular myocytes were enzymatically isolated as previously described. 1 and PLB-KO mice were provided by Dr. E.G. Kranias (University of Cincinnati, OH). All procedures were performed according to the Guiding Principles in the Care and Use of the Animals approved by the Council of the American Physiological Society. Briefly, after anesthesia (isoflurane, 5%), hearts were excised and perfused (5 min, 37°C) with the minimal essential medium (MEM, GIBCO Life Technologies) gassed with 95% O 2 /5% CO 2 , before inclusion of collagenase B (0.5 mg/ml, Boehringer Mannheim) and protease (0.02 mg/ml, Sigma). Triturates were incubated (10 min, 37°C) in the same enzyme solution, washed, and kept in 100 µmol/L Ca 2+ MEM solution. ] 50 nmol/L for wild type (WT), and 25 nmol/L for PLB-KO (calculated using MaxChelator), 1 creatine phosphokinase 5 U/ml; phosphocreatine 10; dextran (Mr: 40,000) 4%; fluo-3 potassium salt 0.05; pH 7.2. To prevent possible basal PKA activity, we included the PKA inhibitory peptide PKI (15 µmol/L from Calbiochem, catalog #116805) in all the bath solutions (except in experiments when exogenous PKA was added). Each cardiomyocyte was first superfused with 50 nM [Ca 2+ ] i (or 25 nM for PLB-KO mice) internal solution and baseline Ca 2+ sparks were recorded. Then, the permeabilized myocyte was exposed to solution designed to phosphorylate the RyR (either by endogenous CaMKII or exogenous pre-activated CaMKII or PKA catalytic subunit; see below). After this period, the phosphorylating solution was washed out and replaced by the original internal solution containing 10 µM okadaic acid (OA) to prevent dephosphorylation while Ca 2+ sparks were again measured. ] i was elevated for 1 min to 500 nM with 1.2 μM exogenous calmodulin. Phosphatase inhibitor okadaic Acid (OA) 2 μM was included to prevent dephosphorylation of CaMKII and its targets and 15 μM PKI was included.
Ca
Pre-activation of Exogenous CaMKII
An alternative approach was to expose the permeabilized myocyte to exogenous CaMKII that was preactivated by autophosphorylation (which allows CaMKII to remain active, even after [Ca In some experiments, CaMKII inhibitor AIP (1 µM) was included for a negative control. This preactivated CaMKII with Ca/CaM was then rapidly diluted into final superfusate with free [Ca 2+ ] restored to 50 nM (with 6 μg/ml CaMKII, 1.2 μM CaM, 10 µM OA and 15 µM PKI) and then exposed to the permeabilized myocyte.
Immunoprecipitation and CaMKII Phosphorylation of RyR2
RyR2 channels were immunoprecipitated from 500 µg homogenate or cell lysate with antibody (MA3-916, Affinity BioReagents Inc) in 0.5 ml of 62.5 mmol/L Tris-HCl buffer (pH 7.5), 0.9% NaCl, 0.5mmol/L NaF, 1% Triton-X, and protease inhibitors for 2 hours at 4°C. The samples were then incubated with protein G Sepharose beads (Sigma) overnight at 4°C, after which the beads were washed five times with CaMKII phosphorylation buffer (50 mol/L Tris-HCl, 10 mmol/L MgCl 2 , 2 mmol/L DDT, 0.1 mmol/L Na 2 EDTA, pH 7.5). CaMKII 250 U (New England Biolabs) was activated with 100 µmol/L ATP, 1.2 µmol/L calmodulin and 0.2 mmol/L CaCl 2 . CaMKII phosphorylation of immunoprecipitated RyR2 was initiated by addition of autophosphorylated CaMKII and γP 32 -ATP to a final specific activity of 300 µCi/µmol. The reaction was terminated with 5 µl of stop solution (10% SDS, 300 mM EGTA and 0.25 mM DTT) after incubation for different times. Samples were heated to 95°C, size-fractionated on 5% SDS-PAGE, exposed to film and RyR2 radioactivity was quantified using Unscan it software. The amount of RyR2 protein was determined by immunoblotting with RyR antibody.
FKBP Co-Immunoprecipitation with RyR2
Myocytes from both WT and PLB-KO mice were treated in three conditions: 1) no treatment, as control group; 2) incubation of permeabilized myocytes (by saponin 100ug/ml) with PKA catalytic subunit (1000 units/ml, cat # 539481, Calbiochem) for 5 min to mimic functional experiments; 3) incubation of permeabilized myocytes with PKI (15 µM, cat # 116805, Calbiochem) for 5 min. Reactions were terminated by adding solubilization buffer and then snap-frozen in liquid nitrogen and stored at -80 o C. Homogenates were treated in a similar way. Total FKBP were measured as described 2 by using anti-FKBP12 (1:1000, a gift from Dr. A.R. Marks, Columbia University, New York). Proteins were transferred to PVDF membranes, and blocked with 5% milk and 0.05% Tween 20 in PBS. After incubation with secondary antibodies, immunoreactive proteins were detected with enhance chemiluminescence (ECL, from Pierce) and proteins were quantified. For FKPB studies RyR2 channels were immunoprecipitated with antibody (MA3-925, Affinity BioReagents Inc) from 500 µg of homogenate or cell lysate in 0.5 ml of RIPA buffer (150 mM NaCl, 50 mM Tris-HCl, pH 7.4, 1% NP40, 1% Na-deoxycholate, 0.1% SDS, 2 mM EDTA, 50 mM NaF) and protease inhibitors overnight at 4°C. Samples were then incubated with protein G Sepharose beads for 2h at 4°C, after which the beads were washed 3 times with RIPA buffer. Samples were split in half and run on both 15% polyacrylamide gels (immunoblotted by anti-FKBP) and on 6% gels for measurement of RyR. Data Analysis Ca 2+ spark were analyzed as previously described. 1 Briefly, Ca 2+ spark amplitudes were normalized (F/F 0 ) to fluorescence baseline (F 0 ). Ca 2+ spark duration was the full-duration half-maximum (FDHM) and width was the full-width half-maximum (FWHM). Ca 2+ spark frequency (CaSpF) was normalized to time and spatial size of the volume elements (or voxels) of the cell from which Ca sparks are measured. It is based on point spread function of the confocal microscope. Under our conditions (zoom = 3.0), the width and length of one voxel is 0.2 μm & 0.2 μm, and the depth (assumed) is 1 μm, so the voxel is 0.04 μm 3 . The fluorescence images were recorded in longitudinal line-scan mode (512 pixels per line), such that the volume of one scan line corresponds to 0.04 μm 3 times the number of pixels that are within the cell length. Results are expressed as mean±SEM. Significance (P<0.05) was determined using Student's t test. 
